SEATTLE — Patients who develop certain subtypes of geographic atrophy may be at risk for a decline in health-related quality of life, according to research presented at the Association for Research in Vision and Ophthalmology meeting.
“In our study of participants in the AREDS (Age-Related Eye Disease Study) clinical trial who developed GA during the AREDS, we found that health-related quality of life measures declined faster in the period after GA developed compared with the period before GA developed,” Susan Vitale, PhD, MHS, research epidemiologist in the division of